63/100B409.28
USD
5.31
(1.31%)
Post Trading·411.20USD+1.92(+0.47%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
Unitedhealth Group financials
Yes. Unitedhealth Group earned 15.88B USD of net income over the last twelve months, 3.5% of its revenue. It made a profit in 38 of its 41 fiscal years since 1985. Its last loss was in fiscal year 1998.
- Revenue (TTM)
- 449.66B USD
- Net income (TTM)
- 15.88B USD
- Free cash flow (TTM)
- 22.83B USD
- Cash and short-term investments
- 28.55B USD
- Total debt
- 74.33B USD
- Shareholders' equity
- 104.13B USD
Cash, debt and equity as of 30 Sept 2026.
Unitedhealth Group earnings
Next earnings · Q4 FY2026
EPS estimate
2.28 USD
Revenue estimate
112.26B USD
Last quarter · Q3 FY2026
EPS4.69Beat +13.3%Revenue112.70BBeat +1.2%
Revenue
ReportedEstimate
EPS
ReportedEstimate
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2027 | 5.32 | — | — | +13.39% | 116.49B | — | — | +3.36% | |
| Q2 FY2027 | 6.92 | — | — | +8.39% | 115.32B | — | — | +2.93% | |
| Q1 FY2027 | 8.14 | — | — | +12.64% | 113.50B | — | — | +1.59% | |
| Q4 FY2026 | 2.28 | — | — | +8.06% | 112.26B | — | — | -0.84% | |
| Q3 FY2026 | 4.14 | 4.69 | +13.29% | +60.62% | 111.31B | 112.70B | +1.25% | -0.41% | |
| Q2 FY2026 | 4.91 | 6.38 | +29.94% | +56.37% | 110.81B | 112.03B | +1.11% | +0.37% | |
| Q1 FY2026 | 6.58 | 7.23 | +9.88% | +0.42% | 109.43B | 111.72B | +2.09% | +1.96% | |
| Q4 FY2025 | 2.10 | 2.11 | +0.48% | -69.02% | 113.77B | 113.22B | -0.49% | +12.31% | |
| Q3 FY2025 | 2.80 | 2.92 | +4.29% | -59.16% | 113.03B | 113.16B | +0.12% | +14.10% | |
| Q2 FY2025 | 4.45 | 4.08 | -8.31% | -40.00% | 111.52B | 111.62B | +0.08% | +14.06% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 27.18 | — | — | +16.07% | 487.83B | — | — | +5.34% |
| FY2027 | 23.42 | — | — | +13.67% | 463.11B | — | — | +3.30% |
| FY2026 | 20.60 | — | — | +26.32% | 448.33B | — | — | +0.17% |
| FY2025 | 16.32 | 16.31 | -0.06% | -41.06% | 447.86B | 447.57B | -0.06% | +12.84% |
| FY2024 | 27.61 | 27.67 | +0.23% | +10.15% | 400.99B | 396.63B | -1.09% | +7.68% |
| FY2023 | 24.96 | 25.12 | +0.65% | +13.20% | 369.14B | 368.33B | -0.22% | +13.63% |
| FY2022 | 22.02 | 22.19 | +0.75% | +16.73% | 323.88B | 324.16B | +0.09% | +12.71% |
Unitedhealth Group growth and profitability
Full income statement- Revenue (TTM)
- 449.66B USD
- Net income (TTM)
- 15.88B USD
- Gross margin
- 22.81%
- Operating margin
- 5.32%
- Net margin
- 3.53%
Revenue / Net income
Revenue Net income Net margin
How Unitedhealth Group makes its money
Premiums352.23B 78.7%
Products53.38B 11.9%
Services38.04B 8.5%
Investment and other income3.92B 0.9%
Revenue447.57B 100.0%
Cost of revenue364.65B 81.5%
Gross profit82.92B 18.5%
Other operating expenses63.95B 14.3%
Operating income18.96B 4.2%
Tax1.89B 0.4%
Other expense5.02B 1.1%
Net income12.06B 2.7%
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
Unitedhealth Group revenue breakdown
By product
FY2025
78.7%Premiums11.9%Products8.5%Services0.9%Investment and other income
| Segment | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Premiums | 352.23B | 78.7% | — |
| Products | 53.38B | 11.9% | — |
| Services | 38.04B | 8.5% | — |
| Investment and other income | 3.92B | 0.9% | — |
Operating and free cash flow
Full cash flow statementOperating cash flow Free cash flow
Unitedhealth Group financial health
Full balance sheet- Cash and short-term investments
- 28.55B USD
- Total debt
- 74.33B USD
- Net cash
- -45.78B USD
- Free cash flow (TTM)
- 22.83B USD
- Current ratio
- 0.74
- Debt to equity
- 0.71
- Piotroski score
- 8 / 9
- Altman Z-score
- 3.08
Cash, debt and free cash flow
Cash and short-term investments Total debt Free cash flow
Assets, liabilities and equity
Total assets Total liabilities Shareholders' equity
Unitedhealth Group valuation
- Price to earnings ratio (TTM)
- 23.36
- Forward P/E (FY2026)
- 19.87
- Price to sales (TTM)
- 0.82
- Price to book
- 3.53
- EV / EBITDA (TTM)
- 14.76
Capital structure
Market capitalization
367.37B USD
+
Total debt
74.33B USD
−
Cash and short-term investments
28.55B USD
=
Enterprise value
413.15B USD
Valuation over time
P/EForward P/EForward P/E · EstimateEstimate
Unitedhealth Group against its own history
Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.
Its peers: CVS Health, Elevance Health, Cigna, and Humana, the US Medical - Healthcare Plans companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.
- P/E (today)Below its median23.49.940.3
- Gross marginLowest in 5 years18.5%18.5%24.6%Against its peers: 2 of 5Peers' median 14.2%
- Operating marginLowest in 5 years4.2%4.2%8.8%Against its peers: 1 of 5Peers' median 3.0%
- Net marginLowest in 5 years2.7%2.7%6.2%Against its peers: 2 of 5Peers' median 1.5%
- Return on equityLowest in 5 years12.8%12.8%25.9%Against its peers: 3 of 5Peers' median 9.8%
- Free cash flow marginLowest in 5 years3.6%3.6%7.2%Against its peers: 1 of 5Peers' median 1.8%
- Revenue growthBelow its median11.8%7.7%14.6%Against its peers: 2 of 5Peers' median 10.7%
- EPS growthBelow its median-14.7%-35.0%17.1%Against its peers: 4 of 5Peers' median -1.8%
- Debt to EBITDAHighest in 5 years3.40×1.70×3.40×Against its peers: 2 of 5Peers' median 3.94×
- Current ratioBelow its median0.790.770.83Against its peers: 4 of 5Peers' median 0.85
Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.
Unitedhealth Group dividends
- Annual dividend
- 9.28 USD
- Dividend yield (indicated)
- 2.27%
- Payout ratio
- 51.71%
- Years of dividend growth
- 17
- Frequency
- Quarterly
- Last payment
- 2.32 USD
- Last ex-dividend date
- 14 Sept 2026
- Last payment date
- 22 Sept 2026
Dividends per share
Unitedhealth Group ownership
- Institutions
- 88.55%
- Institutional holders
- 3,569 (+350)
- Free float
- 99.76%
InstitutionsOthers
As of 30 Jun 2026
Insider trading
| Quarter | Purchases | Sales | Shares acquired | Shares disposed of |
|---|---|---|---|---|
| Q3 2026 | 0 | 2 | 2.52K | 3.11K |
| Q2 2026 | 0 | 1 | 3.64K | 1.82K |
| Q1 2026 | 0 | 0 | 208.62K | 3.85K |
| Q4 2025 | 0 | 0 | 2.76K | 55.00K |
Shares outstanding
Basic shares Diluted shares Change in diluted shares
Common questions about Unitedhealth Group's financials
Source: Financial Modeling Prep